艾迪药业 (688488)
Jiangsu Aidea Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 42078.28
- Circulating A-Shares(W): 42078.28
- Earnings Per Share(RMB): -0.0200
- Net Assets Per Share(RMB): 2.3243
- Operating Revenue(W RMB): 55240.02
- Total Profit(W RMB): 2662.29
- **Net Profit Attributable to Parent(W RMB) **: -684.05
- Net Profit Growth Rate(%): 88.78
- Weighted Return on Equity(%): -0.7000
- Operating Cash Flow Per Share(RMB): 0.0650
- Undistributed Profit Per Share(RMB): -0.8116
- Capital Reserve Per Share(RMB): 2.1102
2. Main Business
The main business covers:
- Production and sales of human-derived protein products
- Generic drug business
- Distribution of Abbott's HIV diagnostic equipment and reagents
- Anti-HIV related products
3. Company Basic Information
- Company Name: Jiangsu Aidea Pharmaceutical Group Co., Ltd.
- Listing Date: 2020-07-20
- Industry: Pharmaceutical Manufacturing
- Address: No. 69 West Xinganquan Road, Hanjiang District, Yangzhou City, Jiangsu Province
- Website: https://www.aidea.com.cn/
- Company Profile: The company was established in 2019 through the overall transformation of Jiangsu Aidea Pharmaceutical Co., Ltd., focusing on drug research and development, production and sales. Its main businesses include human-derived protein products, generic drugs, and distribution of HIV diagnostic equipment and reagents.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Guangzhou Weimei Investment Co., Ltd. | Corporate Entity | 9450.00 | 22.46 |
| 2 | Weimei Investment (Hong Kong) Co., Ltd. | Corporate Entity | 7769.34 | 18.46 |
| 3 | AEGLE TECH LIMITED | Corporate Entity | 1620.00 | 3.85 |
| 4 | Invesco Great Wall Business Model优选混合型证券投资基金(LOF)A类 | Fund | 622.90 | 1.48 |
| 5 | Shanghai Tongxiao Investment Development Center (Limited Partnership)-Tongxiao Zhiyuan Changjing No.1 Private Securities Investment Fund | Private Securities Investment Fund | 573.08 | 1.36 |
| 6 | China Universal Healthcare Mixed Securities Investment Fund | Fund | 466.07 | 1.11 |
| 7 | Suzhou Guantianxia Investment Co., Ltd. | Corporate Entity | 450.00 | 1.07 |
| 8 | Penghua Pharmaceutical Technology Stock Securities Investment Fund A Class | Fund | 412.55 | 0.98 |
| 9 | Yongwin Pharmaceutical Health Stock Securities Investment Fund A Class | Fund | 115.73 | 0.28 |
| 10 | Hongtu Innovation Healthcare Stock Initiated Securities Investment Fund | Fund | 75.46 | 0.18 |
5. Concept Sectors
- Generic Drugs
- Innovative Drugs
- DeepSeek
- Margin Trading & Securities Lending
- Consecutive Losses
- Restructuring Stocks
- Specialized, Refined, Special and New Enterprises
- SSE Innovation
- Sci-Tech Innovation Growth
- Sci-Tech Innovation 200
Remarks
- Data update date: 2025-11-07
- Data source: Public Market Information